Company / Operating Margin
NovoCure Ltd Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-23.5%
FY2025
5-year range
-45.7% / -8.3%
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#124 of 143
Health Care
What the data says
NovoCure Ltd's operating margin of -23.5% is lower than 87% of companies in the Health Care sector (FY2025). Improved from -45.7% to -23.5% over the past 2 years.
Based on SEC 10-K filings.
-23.5% in FY2025 with a 5-year CAGR of -29.6%.
Improved from -45.7% to -23.5% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -6.8pp
- 5-Year Change
- -29.6pp
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 143This company -23.5% Sector average -295.7%
▼
+92.1% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 16.7% year-over-year.
- Currently 272.2pp above the Health Care sector average.
- Peak operating margin was recorded in FY2020.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -23.5% | +16.7% |
| FY2024 | -28.2% | +38.4% |
| FY2023 | -45.7% | -174.8% |
| FY2022 | -16.6% | -100.7% |
| FY2021 | -8.3% | -234.8% |
| FY2020 | 6.2% | +2465.4% |
| FY2019 | -0.3% | +98.1% |
| FY2018 | -13.6% | +38.9% |
| FY2017 | -22.2% | +84.0% |
| FY2016 | -139.1% | +55.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026